Journals / Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi / 2008 / Cilt: 22 - Sayı: 1

Serotonin syndrome

Serotonin sendromu

Pages
27–38
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Although the majority of cases improve with symptomatic and supportive care to treat hypertermia and autonomic dysfunction, severe cases need intensive care and require mechanical ventilation.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Serotonin syndrome results from excessive activation of serotonin (5- hydroxytryptamine; 5-HT) receptors peripherial and central nervous system.
📊
Key Findings & Data:The clinical manifestations are a triad of altered mental status, otonomic dysfunction and neuromuscular exitability.
💡
Conclusion & Impact:Although the majority of cases improve with symptomatic and supportive care to treat hypertermia and autonomic dysfunction, severe cases need intensive care and require mechanical ventilation.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Serotonin syndrome results from excessive activation of serotonin (5- hydroxytryptamine; 5-HT) receptors peripherial and central nervous system. The clinical manifestations are a triad of altered mental status, otonomic dysfunction and neuromuscular exitability. The syndrome caused by the administration of one or more drugs having serotonergic activity. Serotonin syndrome may complicate the administration of drugs used in anesthetic practice, including meperidine, fentanyl and tramadol. Although the majority of cases improve with symptomatic and supportive care to treat hypertermia and autonomic dysfunction, severe cases need intensive care and require mechanical ventilation.

Özet

Serotonin sendromu periferde ve santral sinir sisteminde bulunan serotonin (5-hidroksi triptamin; 5-HT) reseptörlerinin aşırı uyarılması sonucu gelişir. Klinik bulgular mental durum değişiklikleri, otonomik disfonksiyon ve nöromusküler uyarılmadan oluşan bir triadı içerir. Serotonerjik etkili bir veya daha fazla ilacın bir arada kullanılması bu sendroma yol açar. Serotonin sendromu anestezide kullanılan meperidin, fentanil ve tramadol gibi ilaçlarla daha karmaşık bir hale gelebilir. Olguların büyük bir kısmı hipertermi ve otonomik disfonksiyonu önleyici destek ve semptomatik tedavi ile düzelirken, ağır olgularda yoğun bakım ve mekanik ventilasyon gereksinimi söz konusudur.

🔖

Cite This Article

ÖZKARDEŞLER, S. (2008). Serotonin syndrome. Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi, Cilt: 22 - Sayı: 1, 27–38. https://ajindex.com/articles/197120

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (20)

  1. Anaesth Intensive Care 2005; 33: 181- 187
  2. Bijl D. The serotonin syndrome. Neth J Med 2004; 62: 309 - 313
  3. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med 2005; 11: 1112 -1123
  4. Eadie MJ. Convulsive ergotizm: epidemics of the serotonin syndrome? Lancet Neurol 2003; 2: 429 - 434
  5. Ganetsky M, Brush E. Serotonin syndrome: what have we learned? Clin Pediatr Emerg Med 2005; 6: 103 - 108
  6. Martin TG. Serotonin syndrome. Ann Emerg Med 1996; 28: 520 - 526
  7. Oates JA, Sjoerdsma A. Neurologic effects of tryrtophan in patients receiving a monoamino oxidase inhibitor. Neurology 1960; 10: 1076 - 1077
  8. Smith B, Prockop DJ. Central-nervous-system effects of ingestion of L-tryptophan by normal subjects. NEJM 1962; 267:1338 - 1341
  9. Özdemir S, Kocabaşoğlu N. Serotonin sendromuna güncel bir yaklaşım. Klinik Psikofarmakoloji Bülteni 2007; 17: 217 - 225
  10. Dunkley EJ, Isbister GK, Sibbritt D, Dawson AH, Whyte IM. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM 2003; 96: 635 - 642
  11. Goldberg RJ. Selective serotonin reuptake inhibitors. Arch Fam Med 1998; 7: 78 - 84
  12. Isbister GK, Bowe SJ, Dawson A, Whyte IM. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol 2004; 42: 277 - 285
  13. Watson WA, Litovitz TL, Rodgers GC Jr, et al. 2002 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2003; 21: 353 - 421
  14. Mackay FJ, Dunn NR, Mann RD. Antidepressants and the serotonin syndrome in general practice. Br J Gen Pract 1999; 49: 871 - 874
  15. Gill M, LoVecchio F, Selden B. Serotonin syndrome in a child after a single dose of fluvoxamine. Ann Emerg Med 1999; 33: 457 - 459
  16. Isbister GK, Dawson A, Whyte IM, Prior FH, Clancy C, Smith AJ. Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome? Arch Dis Child Fetal Neonatal 2001; 85: 147 - 148
  17. Laine K, Heikkinen T, Ekblad U, Kero P. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Arch Gen Psychiatry 2003; 60: 720 -726
  18. De Ponti F. Pharmacology of serotonin: What a clinician should know. Gut 2004; 53: 1520 - 1535
  19. Caplin ME; Buscombe JR, Hilson AJ, Jones AL, Watkinson AF, Burroughs AK. Carsinoid tumour. Lancet 1998; 352: 799 - 805
  20. Sternbach H. The serotonin syndrome.